The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksERGO.L Regulatory News (ERGO)

  • There is currently no data for ERGO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - ERGOMED PLC

6 Oct 2023 14:40

RNS Number : 0260P
Barclays PLC
06 October 2023
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

 

Barclays PLC.

(b)

Owner or controller of interest and short

 

 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

ERGOMED PLC

 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

 

 

offeror/offeree, state this and specify identity of

 

offeror/offeree:

(e)

Date position held/dealing undertaken:

05 Oct 2023

(f)

In addition to the company in 1(c) above, is the discloser making

NO

 

 

 

disclosures in respect of any other party to the offer?

 

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

 

 

to which the disclosure relates following the dealing(if any)

 

Class of relevant security:

1p ordinary

 

Interests

Short Positions

 

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

 

and/or controlled:

 

 

860,114

1.69%

22,746

0.04%

(2)

Cash-settled derivatives:

 

 

 

 

 

and/or controlled:

 

 

21,539

0.04%

849,732

1.67%

(3)

Stock-settled derivatives (including options)

 

 

 

 

 

and agreements to purchase/sell:

 

 

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

 

TOTAL:

 

 

881,653

1.73%

872,478

1.71%

(b)

Rights to subscribe for new securities (including directors and other executive

 

 

options)

 

 

 

 

 

 

Class of relevant security in relation to

 

 

 

 

which subscription right exists

 

 

 

 

Details, including nature of the rights

 

 

 

 

concerned and relevant percentages:

 

 

 

 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

 

 

 

 

 

Class of relevant

Purchase/sale

Number of

Price per unit

security

 

securities

 

1p ordinary

Purchase

8,838

13.3996 GBP

1p ordinary

Purchase

3,241

13.4000 GBP

1p ordinary

Purchase

1,960

13.3793 GBP

1p ordinary

Purchase

1,045

13.3800 GBP

1p ordinary

Purchase

18

13.4377 GBP

1p ordinary

Sale

566,993

13.4000 GBP

1p ordinary

Sale

4,623

13.3915 GBP

1p ordinary

Sale

1,052

13.3800 GBP

1p ordinary

Sale

542

13.4011 GBP

1p ordinary

Sale

274

13.4007 GBP

1p ordinary

Sale

223

13.3804 GBP

 

 

 

 

 

 

 

 

(b)

Cash-settled derivative transactions

 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

 

reference

unit

security

 

 

securities

 

1p ordinary

SWAP

Short

4,193

13.4000 GBP

1p ordinary

SWAP

Short

4,645

13.3993 GBP

 

 

 

 

 

 

 

 

(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

 

date

money

relevant

 

selling,

securities

per unit

 

 

paid/

security

 

varying etc

to which

 

 

 

received

 

 

 

option

 

 

 

per unit

 

 

 

relates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)

Exercising

 

 

 

 

 

 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

 

 

securities

unit

 

 

 

 

 

 

 

 

 

 

 

 

 

(d)

Other dealings (including subscribing for new securities)

 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

 

 

applicable)

 

 

 

 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

 

 

formal or informal, relating to relevant securities which may be an inducement to deal

 

 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

 

to the offer or any person acting in concert with a party to the offer:

 

 

 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

 

 

the person making the disclosure and any other person relating to:

 

 

(i) the voting rights of any relevant securities under any option; or

 

 

 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

 

 

any derivative is referenced:

 

 

 

 

 

 

NONE

(c)

Attachments

 

 

 

 

 

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

06 Oct 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETFLFVVIDLRIIV
Date   Source Headline
1st Mar 20217:00 amRNSTotal Voting Rights
25th Feb 20218:42 amRNSHolding(s) in Company
10th Feb 20217:00 amRNSNotice of Preliminary Results
26th Jan 20218:42 amEQSErgomed (ERGO): PrimeVigilance excels; CRO strengthened in US
26th Jan 20217:00 amRNSErgomed 2020 Trading Update
4th Jan 20217:00 amRNSTotal Voting Rights and Block Listing Return
15th Dec 20208:00 amEQSErgomed (ERGO): MedSource acquisition to boost US CRO business
14th Dec 20207:00 amRNSAcquisition of MedSource
24th Nov 20204:34 pmRNSHolding(s) in Company
18th Nov 20207:00 amRNSShare Capital Reduction Effective
11th Nov 20207:00 amRNSErgomed to Present at Jefferies Conference
2nd Nov 20207:00 amRNSTotal Voting Rights
21st Oct 20205:26 pmRNSHolding(s) in Company
19th Oct 202010:12 amRNSResult of General Meeting
12th Oct 20205:51 pmRNSHolding(s) in Company
1st Oct 20207:00 amRNSProposed Capital Reduction
1st Oct 20207:00 amRNSTotal Voting Rights
23rd Sep 20207:06 amRNSSecond Price Monitoring Extn
23rd Sep 20207:03 amRNSPrice Monitoring Extension
22nd Sep 20204:40 pmRNSSecond Price Monitoring Extn
22nd Sep 20204:35 pmRNSPrice Monitoring Extension
22nd Sep 20207:00 amRNSInterim Results
9th Sep 20201:50 pmRNSHolding(s) in Company
1st Sep 20207:00 amRNSTotal Voting Rights
20th Aug 202011:32 amRNSHolding(s) in Company
20th Aug 20207:00 amRNSNotice of Interim Results
14th Aug 20204:19 pmRNSHoldings in Company
4th Aug 20207:00 amRNSExercise of Share Options and Total Voting Rights
3rd Aug 20207:00 amRNSTotal Voting Rights
23rd Jul 20201:02 pmRNSHoldings in Company
22nd Jul 202012:57 pmRNSHolding(s) in Company
21st Jul 20202:14 pmRNSHoldings in Company
21st Jul 20202:13 pmRNSHoldings in Company
21st Jul 20207:00 amRNSErgomed H1 2020 Trading Update
20th Jul 20205:35 pmRNSHolding(s) in Company
20th Jul 20202:08 pmRNSHolding(s) in Company
17th Jul 202012:19 pmRNSHolding(s) in Company
15th Jul 202012:03 pmRNSHolding(s) in Company
6th Jul 20204:14 pmRNSExercise of Share Options and Total Voting Rights
1st Jul 20207:00 amRNSTotal Voting Rights & Block Listing Return
29th Jun 20205:17 pmRNSHoldings in Company
10th Jun 20201:43 pmEQSEdison Inv Research Limited: Edison issues flash on Ergomed (ERGO)
10th Jun 202010:53 amRNSResult of AGM
10th Jun 20207:00 amRNSAnnual General Meeting Statement
1st Jun 20207:00 amRNSTotal Voting Rights
28th May 20207:00 amRNSErgomed to Present at Jefferies Conference
18th May 20207:00 amRNSStrategic Partnership in Intelligent Automation
15th May 20207:00 amRNSNotice of AGM and Annual Report and Board Changes
1st May 20207:00 amRNSTotal Voting Rights
6th Apr 20207:00 amRNSErgomed Announces Second COVID-19 Clinical Study

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.